Back
Arcutis Biotherapeutics Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
10.39
Seasonality Move:
-24.31%
Sell
46
MDGL
Madrigal Pharmaceuticals
Last Price:
233.33
Seasonality Move:
23.49%
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy, Sell or Hold?
- The current Arcutis Biotherapeutics [ARQT] share price is $10.37. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $233.36. The Score for MDGL is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARQT Stock Price Chart
What is Arcutis Biotherapeutics's stock price today?
-
The Arcutis Biotherapeutics share price today is $10.37
The current trend is moderately bullish and ARQT is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $233.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing selling pressure, which indicates risk of future bearish movement.
ARQT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 52.77 | Buy |
Chaikin Money Flow: | -959810 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.07 - 10.91) | Buy |
Bollinger Bands (100): | (8.32 - 10.26) | Buy |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.36 | Sell |
Relative Strength Index (14 RSI): | 39.28 | Sell |
Chaikin Money Flow: | -134535 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (237.51 - 253.37) | Sell |
Bollinger Bands (100): | (224.99 - 277.81) | Sell |
ARQT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.53 | Sell |
20-day SMA: | 10.23 | Buy |
50-day SMA: | 9.91 | Buy |
200-day SMA: | 8.11 | Buy |
8-day EMA: | 10.46 | Sell |
20-day EMA: | 10.27 | Buy |
50-day EMA: | 9.89 | Buy |
200-day EMA: | 8.94 | Buy |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 236.83 | Sell |
20-day SMA: | 244.85 | Sell |
50-day SMA: | 259.42 | Sell |
200-day SMA: | 242.46 | Sell |
8-day EMA: | 237.25 | Sell |
20-day EMA: | 243.14 | Sell |
50-day EMA: | 251.33 | Sell |
200-day EMA: | 239.89 | Sell |
Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.42 per share, an increase next quarter of $3.05 per share, a decrease this year of $9.33 per share, and an increase next year of $10.92 per share.
Arcutis Biotherapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |